The event was an investor/analyst conference call to discuss the company's Q1FY27 financial results.
The call was held on August 13, 2026.
The stated purpose of the event was the discussion of quarterly financial results for Q1 FY2026-27.
The company has uploaded the audio recording of this conference call to its official website.
The recording is available at the specific URL: https://www.marksanspharma.com/earnings-call-transcripts.html.
The disclosure is made pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The letter is signed by Harshavardhan Panigrahi, Company Secretary.
Additional Notes Section
This is a procedural announcement to inform the exchanges of the recording's availability; no financial data, guidance, or strategic updates are disclosed in this specific document.
The document itself does not list any management participants or indicate if a presentation deck or transcript was also released.
The communication is a standard compliance filing and contains no unpublished price sensitive information (UPSI).
